Global Vaccine Adjuvants Market Report 2024

Vaccine Adjuvants Global Market Report 2024 – By Product Type (Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types), By Route of Application (Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants), By Route of Administration (Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal), By Disease (Cancer, Infectious Diseases, Other Diseases) – Market Size, Trends, And Global Forecast 2024-2033

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Vaccine Adjuvants Global Market Report 2023

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Vaccine Adjuvants Market Definition And Segments

Vaccine adjuvants are compounds or ingredients used in vaccines that enhance the body's immunogenic response to antigens that lack immunostimulatory capabilities and help to create a stronger immune response.

The main types of products of vaccine adjuvants are adjuvant emulsions, pathogen components, particulate adjuvants, combination adjuvants, and others such as saponin-based adjuvants. An adjuvant emulsion is a mixture of two or more ordinarily immiscible liquids. The route of application includes human vaccine adjuvants and veterinary vaccine adjuvants administered through oral, intramuscular, intranasal, subcutaneous, and intradermal routes to treat cancer, infectious diseases, and other diseases including zoonotic diseases.

The vaccine adjuvants market covered in this report is segmented –

1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types

2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants

3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal

4) By Disease: Cancer, Infectious Diseases, Other Diseases

The vaccine adjuvants market size has grown strongly in recent years. It will grow from $1.77 billion in 2023 to $1.91 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to increasing vaccine development, prevalence of infectious diseases, government initiatives and immunization programs, research and development investments, globalization of vaccine distribution.

The vaccine adjuvants market size is expected to see strong growth in the next few years. It will grow to $2.62 billion in 2028 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to pandemic preparedness, expanding vaccine portfolio, global immunization goals, collaborations and partnerships, focus on therapeutic vaccines. Major trends in the forecast period include advancements in adjuvant technologies, focus on immunogenicity enhancement, combination adjuvants for enhanced effectiveness, demand for safer and well-tolerated adjuvants, personalized vaccines and adjuvants.

Rising Infectious Disease Prevalence Fuels Growth In The Vaccine Adjuvants Market

The rising prevalence of infectious diseases is expected to propel the growth of the vaccine adjuvants market going forward. Infectious diseases refer to infections caused by viruses, bacteria, fungi, or parasites. Vaccines are used to treat these infectious diseases such as hepatitis B (HBV), hepatitis C (HCV), HIV, malaria, syphilis, and brucellosis. For instance, according to the 2022 World Health Organization (WHO) report, an estimated 10.6 million people are infected with tuberculosis globally in 2021, 1.6 million died, and 1.5 million people acquired HIV in 2021 while 650,000 people lost their lives due to it. Therefore, the rising prevalence of infectious diseases will drive the vaccine adjuvants market.

Elevated Funding For Vaccine Research Initiatives Catalyst For Growth In The Vaccine Adjuvants Market

The growing funding for vaccine research activities is expected to propel the growth of the vaccine adjuvants market going forward. Vaccine research activities can be defined as comprehensive scientific endeavors aimed at developing, testing, and improving vaccines to prevent infectious diseases. Research activities play a vital role in developing, testing, and optimizing potential adjuvant candidates from various sources, including natural products, synthetic compounds, and even bacteria or viruses. For instance, in October 2023, the United States Department of Health and Human Services, a US-based provider of essential human services, announced Project NextGen with a $500 Million investment to begin developing Phase 2b clinical trial plans and technologies that develop cutting-edge next-generation vaccination and treatment platforms. Therefore, the growing funding for vaccine research activities is driving the growth of the vaccine adjuvants market.

Major companies operating in the vaccine adjuvants market report are GlaxoSmithKline Plc., Novavax Inc., SPI Pharma Inc., Agenus Inc., CSL Limited, InvivoGen Limited., Brenntag Biosector A/S, Adjuvatis, Merck KGaA, Croda International PLC, Seppic Inc., OZ Biosciences, Avanti Polar Lipids Inc., Astellas Pharma Inc., Virometix AG, MPV Technologies Limited, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd., SBI Biotech Co. Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc., Aphios Corporation

Surge In Strategic Partnerships Shapes The Landscape Of The Vaccine Adjuvants Market

Strategic partnership is a key trend gaining popularity in the vaccine adjuvants market. Many companies operating in the vaccine adjuvants market are looking for partnerships to strengthen their position in the market. For instance, in October 2021, Dynavax Technologies, a US-based biotech company partnered with the U.S. Department of Defense to develop an adjuvanted plague vaccine using Dynavax's CpG 1018 adjuvant. Furthermore, in September 2020, Valneva SE, a France-based biotech company, partnered with Dynavax, a US-based biotech company to produce an adjuvant for the COVID-19 vaccine.

Innovation In The Vaccine Adjuvants Market With A Plant-Based Squalene For Enhanced Vaccine Efficacy

Major companies operating in the vaccine adjuvants market are focused on developing innovative products, such as plant-based squalene, to gain a competitive edge in the market. Plant-based squalene is a sustainable and cruelty-free alternative to the traditional squalene derived from shark liver oil. For instance, in December 2022, Evonik Industries AG, a Germany-based specialty chemicals company, launched PhytoSquene, a plant-based squalene for use in adjuvants to boost vaccine efficacy. It is used in adjuvants for parenteral vaccines, with potential for expansion into other pharmaceutical and cosmetic applications. The oil used to make PhytoSquene comes from the herbaceous plant known as amaranth (Amaranthus caudatus), which is grown all over the world. Its botanical origin guarantees purity, quality, and consistency from batch to batch. For patients who are unable to utilize products derived from animals due to cultural or religious beliefs, PhytoSquene offers an additional solution.

Gsk Enhances Portfolio With Acquisition Of Affinivax Inc. In Vaccine Adjuvants Market

In August 2022, GSK PLC, a UK-based pharmaceutical and biotechnology company, acquired Affinivax Inc. for a deal amount of $3.3 billion. The acquisition of Affinivax strengthens GSK's strategy to build a substantial portfolio of specialized novel drugs and vaccines. It comprises a next-generation 24-valent pneumococcal vaccine adjuvant (AFX3772), which is based on the incredibly ground-breaking Multiple Antigen Presenting System (MAPSTM) platform technology and is currently in phase II development. Affinivax Inc. is a UK-based clinical-stage biopharmaceutical company operating in the vaccine adjuvant market.

North America was the largest region in the vaccine adjuvants market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the vaccine adjuvants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The vaccine adjuvants market consists of sales of adjuvant emulsions, pathogen components, particulate adjuvants, combination adjuvants, and saponin-based adjuvants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The vaccine adjuvants market research report is one of a series of new reports from The Business Research Company that provides vaccine adjuvants market statistics, including the vaccine adjuvants industry's global market size, regional shares, competitors with a vaccine adjuvants market share, detailed vaccine adjuvants market segments, market trends, and opportunities, and any further data you may need to thrive in the vaccine adjuvants industry. This vaccine adjuvants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Vaccine Adjuvants Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $1.91 billion
Revenue Forecast In 2033 $2.62 billion
Growth Rate CAGR of 8.2% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types
2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants
3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal
4) By Disease: Cancer, Infectious Diseases, Other Diseases
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled GlaxoSmithKline Plc.; Novavax Inc.; SPI Pharma Inc.; Agenus Inc.; CSL Limited; InvivoGen Limited.; Brenntag Biosector A/S; Adjuvatis; Merck KGaA; Croda International Plc; Seppic Inc; OZ Biosciences; Avanti Polar Lipids Inc; Astellas Pharma Inc; Virometix AG; MPV Technologies Limited; Adjuvance Technologies Inc.; Novartis AG; Vaxine Pty Ltd; SBI Biotech Co. Ltd.; Statens Serum Institute; GSK Vaccines; VaxLiant LLC; VaxForm LLC; Serum Institute of India; Dynavax Technologies Corporation; Vaxcyte Inc.; VBI Vaccines Inc.; Medicago Inc.; Aphios Corporation
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Vaccine Adjuvants Market Characteristics

    3. Vaccine Adjuvants Market Trends And Strategies

    4. Vaccine Adjuvants Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On the Market

    4.2. Ukraine-Russia War Impact On the Market

    4.3. COVID-19 Impact On the Market

    5. Global Vaccine Adjuvants Market Size and Growth

    5.1. Global Vaccine Adjuvants Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Vaccine Adjuvants Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Vaccine Adjuvants Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Vaccine Adjuvants Market Segmentation

    6.1. Global Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Adjuvant Emulsions

    Pathogen Components

    Particulate Adjuvants

    Combination Adjuvants

    Other Product Types

    6.2. Global Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Human Vaccine Adjuvants

    Veterinary Vaccine Adjuvants

    6.3. Global Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Oral

    Intramuscular

    Intranasal

    Subcutaneous

    Intradermal

    6.4. Global Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Cancer

    Infectious Diseases

    Other Diseases

    7. Vaccine Adjuvants Market Regional And Country Analysis

    7.1. Global Vaccine Adjuvants Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Vaccine Adjuvants Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Vaccine Adjuvants Market

    8.1. Asia-Pacific Vaccine Adjuvants Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Vaccine Adjuvants Market

    9.1. China Vaccine Adjuvants Market Overview

    9.2. China Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Vaccine Adjuvants Market

    10.1. India Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Vaccine Adjuvants Market

    11.1. Japan Vaccine Adjuvants Market Overview

    11.2. Japan Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Vaccine Adjuvants Market

    12.1. Australia Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Vaccine Adjuvants Market

    13.1. Indonesia Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Vaccine Adjuvants Market

    14.1. South Korea Vaccine Adjuvants Market Overview

    14.2. South Korea Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Vaccine Adjuvants Market

    15.1. Western Europe Vaccine Adjuvants Market Overview

    15.2. Western Europe Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Vaccine Adjuvants Market

    16.1. UK Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Vaccine Adjuvants Market

    17.1. Germany Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Vaccine Adjuvants Market

    18.5. France Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Vaccine Adjuvants Market

    19.9. Italy Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Vaccine Adjuvants Market

    20.13. Spain Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Vaccine Adjuvants Market

    21.1. Eastern Europe Vaccine Adjuvants Market Overview

    21.2. Eastern Europe Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Vaccine Adjuvants Market

    22.1. Russia Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Vaccine Adjuvants Market

    23.1. North America Vaccine Adjuvants Market Overview

    23.2. North America Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Vaccine Adjuvants Market

    24.1. USA Vaccine Adjuvants Market Overview

    24.2. USA Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Vaccine Adjuvants Market

    25.1. Canada Vaccine Adjuvants Market Overview

    25.2. Canada Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Vaccine Adjuvants Market

    26.1. South America Vaccine Adjuvants Market Overview

    26.2. South America Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Vaccine Adjuvants Market

    27.1. Brazil Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Vaccine Adjuvants Market

    28.1. Middle East Vaccine Adjuvants Market Overview

    28.2. Middle East Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Vaccine Adjuvants Market

    29.1. Africa Vaccine Adjuvants Market Overview

    29.2. Africa Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Vaccine Adjuvants Market Competitive Landscape And Company Profiles

    30.1. Vaccine Adjuvants Market Competitive Landscape

    30.2. Vaccine Adjuvants Market Company Profiles

    30.2.1. GlaxoSmithKline Plc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Novavax Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. SPI Pharma Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Agenus Inc.

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. CSL Limited

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Global Vaccine Adjuvants Market Competitive Benchmarking

    32. Global Vaccine Adjuvants Market Competitive Dashboard

    33. Key Mergers And Acquisitions In The Vaccine Adjuvants Market

    34. Vaccine Adjuvants Market Future Outlook and Potential Analysis

    34.1 Vaccine Adjuvants Market In 2028 - Countries Offering Most New Opportunities

    34.2 Vaccine Adjuvants Market In 2028 - Segments Offering Most New Opportunities

    34.3 Vaccine Adjuvants Market In 2028 - Growth Strategies

    34.3.1 Market Trend Based Strategies

    34.3.2 Competitor Strategies

    35. Appendix

    35.1. Abbreviations

    35.2. Currencies

    35.3. Historic And Forecast Inflation Rates

    35.4. Research Inquiries

    35.5. The Business Research Company

    35.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Vaccine Adjuvants Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Vaccine Adjuvants Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: GlaxoSmithKline Plc. Financial Performance
  • Table 76: Novavax Inc. Financial Performance
  • Table 77: SPI Pharma Inc. Financial Performance
  • Table 78: Agenus Inc. Financial Performance
  • Table 79: CSL Limited Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Vaccine Adjuvants Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Vaccine Adjuvants Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Vaccine Adjuvants Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Vaccine Adjuvants Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Vaccine Adjuvants Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Vaccine Adjuvants Market, Segmentation By Route of Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: GlaxoSmithKline Plc. Financial Performance
  • Figure 76: Novavax Inc. Financial Performance
  • Figure 77: SPI Pharma Inc. Financial Performance
  • Figure 78: Agenus Inc. Financial Performance
  • Figure 79: CSL Limited Financial Performance
Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company
Read More
Global Gene Therapy Market 2022 – Market Opportunities And Strategies
Read More
The Microbiome Market Share, Market Size, And Growth Rate 2022
Read More
Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the dermatitis market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the insulin drugs market research report 2022 with industry size, share, segments and market growth
Read More
Genetically Modified Crops Global Market Report 2024 – By Trait (Herbicide Tolerance (HT), Insect Resistance (IR), Stacked Traits (ST), Other Traits), By Crop (Soybean, Cotton, Maize, Oilseed Rape, Other Crops), By Technique (Gene Guns, Electroporation, Microinjection, Agrobacterium, Other Techniques), By Type of Modification (Transgenic, Cis-genic, Sub-genic, Multiple Trait Integration, By Application (Scientific Research, Agriculture Crops) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Agricultural Implement Global Market Report 2024 – By Type (Farm Machinery And Equipment, Lawn And Garden Tractor And Home Lawn And Garden Equipment), By Operation (Autonomous, Semi-autonomous, Manual), By Capacity (Small, Medium, Large), By Application (Land Development and Seed Bed Preparation, Sowing and Planting, Weed Management, Plant Protection, Harvesting and Threshing, Post-Harvest and Agro Processing) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Ethylene-Petrochemicals Global Market Report 2024 – By Feedstock (Naphtha, Ethane, Propane, Butane, Other Feedstocks), By Application (Polyethylene, Ethylene oxide, Ethylene benzene, Ethylene dichloride, Vinyl Acetate, Alpha Olefins), By End User Industry (Packaging, Automotive, Construction, Agrochemical, Textile) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Emulsifiers Global Market Report 2024 – By Product (Lecithin, Mono And Di-Glycerides, Stearyl Lactylates, Sorbitan Esters, Polyglycerol Esters, Other Products), By Chemical Structure (Natural, Synthetics, Semi-Synthetics), By Application (Food Emulsifiers, Cosmetics And Personal Care, Oilfield Chemicals, Pharmaceutical, Agrochemicals, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
AgroScience Global Market Report 2024 – By Product (Biopesticides, Biostimulants, GM Seeds), By Active Ingredient (Acid-based biostimulants, Extract-based biostimulants), By Application (Crops, Food & Vegetable) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Chitosan Global Market Report 2024 – By Grade (Pharmaceutical Grade, Industrial Grade, Food Grade), By Source (Shrimp, Squid, Crab, Krill, Other Sources), By Application (Water Treatment, Food and Beverages, Cosmetics, Medical and Pharmaceuticals, Agrochemicals, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Chemicals Global Market Report 2024 – By Type (General Chemical Product, Printing Inks, Toiletries, Soap and Cleaning Compounds, Adhesives, Paints and Coatings, Pesticide and Other Agricultural Chemicals, Chemical Fertilizers, Synthetic Rubber and Fibers, Plastic Material and Resins, Ethyl Alcohol and Other Basic Organic Chemical, Other Basic Inorganic Chemical, Synthetic Dye and Pigment, Industrial Gas, Petrochemicals), By Type of Intermediate Chemicals (Methanol, Ethylene Oxide, Propylene Oxide), By End User (Pharmaceuticals, Agrochemicals, Water Treatment, Construction, Paints and Dyes, Oil & Gas, Rubber Chemicals, Surfactants, Personal Care, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Ethylene Global Market Report 2023 – By Feedstock (Naphtha, Ethane, Propane, Butane, Other Feedstocks), By Application (Polyethylene, Ethylene oxide, Ethylene benzene, Ethylene dichloride, Vinyl Acetate, Alpha Olefins), By End User Industry (Packaging, Automotive, Construction, Agrochemical, Textile) – Market Size, Trends, And Global Forecast 2023-2032
View Report

Frequently Asked Questions

What is the definition of the vaccine adjuvants market?

Vaccine adjuvants are compounds or ingredients used in vaccines that enhance the body's immunogenic response to antigens that lack immunostimulatory capabilities and help to create a stronger immune response. For further insights on the vaccine adjuvants market, request a sample here

How will the vaccine adjuvants market drivers and restraints affect the vaccine adjuvants market dynamics? What forces will shape the vaccine adjuvants industry going forward?

The vaccine adjuvants market growth is aided by rising prevalence of infectious diseases. For further insights on the vaccine adjuvants market, request a sample here

What is the forecast market size or the forecast market value of the vaccine adjuvants market?

The vaccine adjuvants market is expected to reach $2.38 billion in 2027 at a rate of 7.7%. For further insights on the vaccine adjuvants market, request a sample here

How is the vaccine adjuvants market segmented?

The global vaccine adjuvants market is segmented as
1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types
2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants
3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal
4) By Disease: Cancer, Infectious Diseases, Other Diseases
For further insights on the vaccine adjuvants market, request a sample here

Which region has the largest share of the vaccine adjuvants market? What are the largest region's market size and growth rate?

North America was the largest region in the vaccine adjuvants market in 2022. For detailed insights on the largest region's market size and growth rate, request a sample here.

Who are the major players in the vaccine adjuvants market?

Key competitors in the vaccine adjuvants market are GlaxoSmithKline Plc, Novavax Inc, SPI Pharma, Agenus Inc, CSL Limited, InvivoGen, Brenntag Biosector A/S, Adjuvatis, Merck KGaA, Croda International Plc, Seppic Inc, OZ Biosciences, Avanti Polar Lipids Inc, Astellas Pharma Inc, Virometix AG, MPV Technologies Limited, Adjuvance Technologies Inc.. For further insights on the vaccine adjuvants market, request a sample here.

What are the key trends in the vaccine adjuvants market?

Major trends influencing the vaccine adjuvants market include strategic partnership. Many companies operating in the vaccine adjuvants market are looking for partnerships to strengthen their position in the market. For further insights on the vaccine adjuvants market, request a sample here.

What are the major opportunities in the vaccine adjuvants market? What are the strategies for the vaccine adjuvants market?

For detailed insights on the major opportunities and strategies in the vaccine adjuvants market, request a sample here.

How does the vaccine adjuvants market relate to the overall economy and other similar markets?

For detailed insights on vaccine adjuvants market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the vaccine adjuvants industry?

For detailed insights on the mergers and acquisitions in the vaccine adjuvants industry, request a sample here.

What are the key dynamics influencing the vaccine adjuvants market growth? SWOT analysis of the vaccine adjuvants market.

For detailed insights on the key dynamics influencing the vaccine adjuvants market growth and SWOT analysis of the vaccine adjuvants industry, request a sample here.